-
14-06-2018, 06:10 PM
#961
I agree FPH looks expensive, but on a casflow basis (of the company, not the share), it still stacks up at a 7% discount rate...which is not awful for what is becoming a low-risk company. MFT is at slightly better than that. I don't think there's much upside relative to market, but there's no downside either.
Certainly, I'd still rather be banking on these two internationally diversified companies compared yo the gentailers he was advocating...
-
14-06-2018, 06:27 PM
#962
Sought after today , 5 million through (re 700,000 on ASX) and at anew high. Flight to quality happening?. A lot of my small caps and microcaps are under the pump atm.
-
14-06-2018, 10:26 PM
#963
Originally Posted by kiora
Is this why todays crossings?
-
18-06-2018, 11:40 AM
#964
An american fund of funds @ 5% plus, 29 mill shareholder ,capital group a keen investor in FPH topping up at a high . 3.8mill bought a few days ago taken them over 5%.
-
20-06-2018, 12:42 PM
#965
Forecast to more than double globally
$482.5 Billion Sleep Apnea Oral Appliances Market - Global Forecasts to 2023 - ResearchAndMarkets.com
Posted: May 24, 2018 6:25 AM NZSTUpdated: May 24, 2018 6:25 AM NZST
DUBLIN --(BUSINESS WIRE)
The "Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (Mad) & Tongue-Retaining Devices (TRD)), Type (Physician Prescribed/Customized Oral Appliances & Online OTC Oral Appliances) - Global Forecasts to 2023" report has been added to ResearchAndMarkets.com'soffering.
The sleep apnea oral appliances market is projected to reach USD 482.5 million by 2023 from an estimated USD 233.2 million in 2018.
The major influencing factors driving the growth of this market are growing popularity of oral appliances in sleep apnea management, technological advancements in oral appliances, a large pool of undiagnosed sleep apnea patients, and growing awareness about sleep apnea. However, complex referral pathways, coupled with long waiting periods at sleep centers, often acts as a deterrent for the effective diagnosis and treatment of sleep apnea. This is expected to restrain market growth in the forecast period.
On the basis of product, the market is segmented into mandibular advancement devices and tongue-retaining devices. In 2017, the mandibular advancement devices segment commanded the largest share of the global sleep apnea oral appliances market. This segment is also expected to register the highest CAGR from 2018 to 2023. The large share and high growth can be attributed to the popularity of MADs backed up by the extensive research available supporting their effectiveness over TRDs.
Based on type, the sleep apnea oral appliances market is segmented into physician-prescribed/customized oral appliances and online OTC oral appliances. The physician-prescribed/customized oral appliances segment is expected to register the highest CAGR of the sleep apnea oral appliances market during the forecast period. The high growth can be attributed to the rising awareness of sleep apnea and increasing patient preference for prescribed and customized oral appliances.
-
21-06-2018, 11:12 PM
#966
Member
SP jumps 32.5 c on the day it goes ex-dividend??? I don't understand this stock.
-
22-06-2018, 10:27 AM
#967
If the above research is reasonably accurate, a possible doubling of revenue in 5 years for FPH is a very attractive low risk fillip for the s/p and great incentive for investors.Track record of increasing earnings continues albeit up a steeper curve?
-
22-06-2018, 10:58 AM
#968
Member
Yes, FPH printed doubling revenue every 5-6 years as their ambition. They simply won't stop until we're all breathing through tubes!
Originally Posted by Joshuatree
If the above research is reasonably accurate, a possible doubling of revenue in 5 years for FPH is a very attractive low risk fillip for the s/p and great incentive for investors.Track record of increasing earnings continues albeit up a steeper curve?
The research you quoted seems to be about "mandibular advancement devices" and "tongue-retaining devices", whatever those are. FPH isn't mentioned though.
-
27-06-2018, 06:51 PM
#969
You're right apologies. heres a bit more re the advantages over cpap below. A friend owns OMH(asx) ,3D printed mouth devices for sleep apnoea. Will have another look, s/p looks to be bottoming. Meanwhile FPH at anew high $15.26!. Who sold a few weeks ago thinking a top was in, incredible isn't it, nuts really.
"The sleep apnea oral appliances market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of the global sleep apnea oral appliances market. The rising prevalence of sleep apnea in the region coupled with the growing demand for alternative treatment options due to poor compliance associated with CPAP is driving the market for sleep apnea oral appliances in the region. In addition, rising awareness regarding the disorder; less complicated reimbursement scenario for oral appliance therapy (OAT); and increased acceptance of OAT by physicians, dentists, patients, and insurance companies are also supporting the growth of the sleep apnea oral appliances market in North America. "
-
27-06-2018, 07:04 PM
#970
Yes I agree its nuts,but if it can double revenue every 5-6 yrs,NP quicker than that, time is your friend
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks